Dihua Yu

发表

Needle-based fluorescence endomicroscopy via structured illumination with a plastic, achromatic objective

Xiao Wang, Tomasz S. Tkaczyk, Shalini Jain, 2013, Journal of biomedical optics.

Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.

Tomasz S Tkaczyk, Rebecca Richards-Kortum, Wei Jia, 2015, Cancer research.

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

Hua Guo, Dihua Yu, Steven Stone, 2010, The American journal of pathology.

Lineage Infidelity of MDA-MB-435 Cells

Gordon B Mills, Dihua Yu, G. Mills, 2004, Cancer Research.

Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

Hua Guo, Dihua Yu, Wen-Chien Huang, 2011, Nature Medicine.

Dissection of Signaling Pathways in Fourteen Breast Cancer Cell Lines Using Reverse-Phase Protein Lysate Microarray

Ioan Tabus, Olli Yli-Harja, Andrea Hategan, 2006, Technology in cancer research & treatment.

Molecular mechanisms of erbB2-mediated breast cancer chemoresistance.

Ming Tan, Dihua Yu, Dihua Yu, 2007, Advances in experimental medicine and biology.

Molecular predictors of response to trastuzumab and lapatinib in breast cancer

Dihua Yu, G. Hortobagyi, M. Hung, 2010, Nature Reviews Clinical Oncology.

Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells

Jun Yao, Dihua Yu, Ping Li, 2001, Oncogene.

ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.

Ming Tan, Dihua Yu, Ping Li, 2006, Cancer research.

Cancer Cell Migration: Integrated Roles of Matrix Mechanics and Transforming Potential

Roger T. Bonnecaze, Muhammad H. Zaman, Jaya Srivastava, 2011, PloS one.

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

Gordon B Mills, Dihua Yu, Jinsong Liu, 2008, Molecular carcinogenesis.

Breast cancer chemosensitivity

Dihua Yu, M. Hung, Dihua Yu, 2007 .

14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.

Hua Guo, Jun Yao, Dihua Yu, 2009, Cancer research.

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Ming Tan, Dihua Yu, Ping Li, 2004, Cancer cell.

Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

Jun Yao, Suyun Huang, Dihua Yu, 2015, Nature.